The Euvichol story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships

Cholera, a diarrheal disease primarily affecting vulnerable populations in developing countries, is estimated to cause disease in more than 2.5 million people and kill almost 100,000 annually. An oral cholera vaccine (OCV) has been available globally since 2001; the demand for this vaccine from affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Odevall, Lina, Hong, Deborah, Digilio, Laura, Sahastrabuddhe, Sushant, Mogasale, Vittal, Baik, Yeongok, Choi, Seukkeun, Kim, Jerome H., Lynch, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203809/
https://www.ncbi.nlm.nih.gov/pubmed/30314912
http://dx.doi.org/10.1016/j.vaccine.2018.09.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203809/
https://www.ncbi.nlm.nih.gov/pubmed/30314912
http://dx.doi.org/10.1016/j.vaccine.2018.09.026

Ejemplares similares